Cystic fibrosis: Update on treatment guidelines and new recommendations

Edward DeSimone, Jennifer Tilleman, Martin E. Giles, Boussina Moussa

Research output: Contribution to specialist publicationArticle

Abstract

Cystic fibrosis (CF) is a genetic disorder that affects various body systems, leading to premature death. Newborn screening in all states has helped identify those who have this disorder and allows for earlier interventions. Although traditionally viewed as a pulmonary disorder, treatments are available to address the various manifestations of CF. Airway clearance, nutritional support, pancreatic-enzyme replacement, and chronic antibiotic therapy are among the current recommended treatments. The most recent development involves the use of cystic fibrosis transmembrane conductance regulators that help to correct the underlying problem rather than just treat the symptoms. Pharmacists can serve an important role in the proper treatment of primary and secondary symptoms of CF.

Original languageEnglish (US)
Pages16-21
Number of pages6
Volume43
No5
Specialist publicationU.S. Pharmacist
StatePublished - May 2018

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmaceutical Science

Fingerprint Dive into the research topics of 'Cystic fibrosis: Update on treatment guidelines and new recommendations'. Together they form a unique fingerprint.

  • Cite this

    DeSimone, E., Tilleman, J., Giles, M. E., & Moussa, B. (2018). Cystic fibrosis: Update on treatment guidelines and new recommendations. U.S. Pharmacist, 43(5), 16-21.